MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile

Which patents cover Milrinone Lactate In Dextrose 5% In Plastic Container, and when can generic versions of Milrinone Lactate In Dextrose 5% In Plastic Container launch?

Milrinone Lactate In Dextrose 5% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, Gland Pharma Ltd, Hikma, Hospira, West-ward Pharms Int, and Woodward. and is included in eight NDAs.

The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5% In Plastic Container

A generic version of MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Summary for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	7
NDAs:	8
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	90
Clinical Trials:	5
Formulation / Manufacturing:	see details
DailyMed Link:	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shanghai Children's Medical Center	Phase 3
Ottawa Heart Institute Research Corporation	Phase 4
Bedford Pharmaceuticals	N/A

See all MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Drug Class	Phosphodiesterase 3 Inhibitor
Mechanism of Action	Phosphodiesterase 3 Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

C01CE	Phosphodiesterase inhibitors
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	076414-001	Aug 18, 2004		DISCN	No	No
Hikma	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075510-001	May 28, 2002		DISCN	No	No
Baxter Hlthcare	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075834-002	May 28, 2002	AP	RX	No	Yes
Woodward	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	077151-001	Jul 20, 2005		DISCN	No	No
Hospira	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075885-001	May 28, 2002		DISCN	No	No